Key result
The antiangiogenic herbal composition Ob-X significantly reduced visceral fat by 20.5% from baseline over 12 weeks, a reduction 1.9 times greater than placebo (p=0.0495).
Why the study?
Does the antiangiogenic herbal composition Ob-X reduce visceral fat in abdominally obese subjects?
Population
80 abdominally obese subjects
Comparison
Ob-X 690 mg orally twice a day for 12 weeks vs Placebo
Design
RCT, randomized, double-blind
Follow-up
12 weeks
Authors
Loading...
May support Ob-X as adjunct for visceral fat reduction; extends antiangiogenic herbal evidence to human metabolic trials.
RCT (n=80)
Double-blind
randomized
Does the antiangiogenic herbal composition Ob-X reduce visceral fat in abdominally obese subjects?
p-value: p=0.0495
The antiangiogenic herbal composition Ob-X significantly reduces visceral fat in abdominally obese subjects over 12 weeks.
Kang et al. (2018) conducted an RCT in Abdominal obesity (n=80). Ob-X vs. Placebo was evaluated on Change in visceral fat (p=0.0495). The antiangiogenic herbal composition Ob-X significantly reduced visceral fat by 20.5% from baseline over 12 weeks, a reduction 1.9 times greater than placebo (p=0.0495).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: